Caplacizumab Biosimilar Nanobody

Caplacizumab Biosimilar Nanobody

SKU: NB0020
205.00 USD In stock Buy at Merchant

Caplacizumab is a humanized nanobody used to treat acquired thrombotic thrombocytopenic purpura and is available in unconjugated and conjugated forms for research purposes.

  • The description claims that caplacizumab treats acquired thrombotic thrombocytopenic purpura.
Specifications
Antibody Production Scale
50 ug, 250 ug, 1 mg
Conjugate
None, FITC, HRP, ADC (custom drug)

AI Readiness

Good foundation, but some important product data is still missing.

74%
3 important fields missing Claim to view full AI report
Data sourced from bicellscientific.com. Last updated: The description was auto-generated by an AI model based on the merchant's description. It may not be accurate or complete.
Claim bicellscientific.com to see AI Product Health

Takes ~2 minutes. No storefront changes.